Algert Global’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Algert Global's CNMD Position: Q1 2026 in Review
Algert Global increased its CONMED (CNMD) stake by 102% in Q1 2026, buying an estimated $1.73M and bringing the position to 84,000 shares worth $2.97M. The position accounts for 0.04% of the portfolio, ranked #600.
Algert Global first reported a position in CNMD in Q1 2024 and has held it in 5 quarters since. The position peaked at $3.33M in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Algert Global held 84,000 shares of CONMED worth $2.97M as of Q1 2026.
- Algert Global bought 42,500 CONMED shares in Q1 2026, an estimated $1.73M.
- CONMED made up 0.04% of Algert Global's portfolio in Q1 2026, its #600 holding.
- Algert Global first reported a position in CONMED in Q1 2024 and has held it in 5 quarters since.
- Algert Global's CONMED position peaked at $3.33M in Q1 2024.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.